Insights

Innovative Therapies Paratek Pharmaceuticals specializes in developing transformative solutions for infectious diseases and challenging conditions, indicating a strong market focus on antimicrobial and specialty therapies that could be expanded into new therapeutic areas or geographies.

Recent Investment The company was acquired by Gurnet Point Capital and Novo Holdings for up to 462 million dollars, reflecting substantial financial backing and a commitment to growth, creating opportunities for partnerships or collaborations to accelerate product development and market penetration.

Market Engagement Active participation in prominent industry conferences such as IDWeek, CHEST, ATS, and ESCMID demonstrates a commitment to showcasing data-driven innovations, which can be leveraged to identify key healthcare providers and opinion leaders for strategic alliances.

Technological Deployment Utilization of advanced tools including Veeva, Tableau, and Minitab indicates a focus on data management and analytics, providing potential sales channels to integrate or enhance healthcare data solutions within their operational framework.

Growth Potential With a revenue range of 250 to 500 million dollars and a dedicated team of up to 500 employees, Paratek presents a significant opportunity for expanding sales efforts around their flagship drug NUZYRA and other pipeline assets in both clinical and commercial stages.

Paratek Pharmaceuticals Tech Stack

Paratek Pharmaceuticals uses 8 technology products and services including Tableau, D2L Brightspace, Open Graph, and more. Explore Paratek Pharmaceuticals's tech stack below.

  • Tableau
    Business Intelligence
  • D2L Brightspace
    Communication And Collaboration
  • Open Graph
    Content Management System
  • Veeva Systems
    IT Infrastructure & Operations Management
  • Microsoft
    Miscellaneous
  • Greenhouse
    Recruitment Marketing
  • Google Tag Manager
    Tag Management
  • Minitab
    Visualisation Software

Media & News

Paratek Pharmaceuticals's Email Address Formats

Paratek Pharmaceuticals uses at least 1 format(s):
Paratek Pharmaceuticals Email FormatsExamplePercentage
First.Last@paratekpharma.comJohn.Doe@paratekpharma.com
92%
Last@paratekpharma.comDoe@paratekpharma.com
4%
First.L@paratekpharma.comJohn.D@paratekpharma.com
2%
FLast@paratekpharma.comJDoe@paratekpharma.com
2%

Frequently Asked Questions

Where is Paratek Pharmaceuticals's headquarters located?

Minus sign iconPlus sign icon
Paratek Pharmaceuticals's main headquarters is located at 75 Park Plaza, 4th Floor Boston, MA 02116, US. The company has employees across 4 continents, including North AmericaAfricaEurope.

What is Paratek Pharmaceuticals's phone number?

Minus sign iconPlus sign icon
You can contact Paratek Pharmaceuticals's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Paratek Pharmaceuticals's stock symbol?

Minus sign iconPlus sign icon
Paratek Pharmaceuticals is a publicly traded company; the company's stock symbol is PRTK.

What is Paratek Pharmaceuticals's official website and social media links?

Minus sign iconPlus sign icon
Paratek Pharmaceuticals's official website is paratekpharma.com and has social profiles on LinkedInCrunchbase.

What is Paratek Pharmaceuticals's NAICS code?

Minus sign iconPlus sign icon
Paratek Pharmaceuticals's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Paratek Pharmaceuticals have currently?

Minus sign iconPlus sign icon
As of October 2025, Paratek Pharmaceuticals has approximately 355 employees across 4 continents, including North AmericaAfricaEurope. Key team members include Chief Executive Officer: E. L.Chief Legal Officer, Corporate Secretary And Chief Compliance Officer: J. L.Chief Financial Officer: C. B.. Explore Paratek Pharmaceuticals's employee directory with LeadIQ.

What industry does Paratek Pharmaceuticals belong to?

Minus sign iconPlus sign icon
Paratek Pharmaceuticals operates in the Pharmaceutical Manufacturing industry.

What technology does Paratek Pharmaceuticals use?

Minus sign iconPlus sign icon
Paratek Pharmaceuticals's tech stack includes TableauD2L BrightspaceOpen GraphVeeva SystemsMicrosoftGreenhouseGoogle Tag ManagerMinitab.

What is Paratek Pharmaceuticals's email format?

Minus sign iconPlus sign icon
Paratek Pharmaceuticals's email format typically follows the pattern of First.Last@paratekpharma.com. Find more Paratek Pharmaceuticals email formats with LeadIQ.

When was Paratek Pharmaceuticals founded?

Minus sign iconPlus sign icon
Paratek Pharmaceuticals was founded in 1996.

Paratek Pharmaceuticals

Pharmaceutical ManufacturingUnited States201-500 Employees

Positive outcomes. Positive patient stories. These are our priorities at Paratek Pharmaceuticals. As a commercial-stage biopharmaceutical company, we develop transformative solutions for patients with infectious diseases and other difficult to treat conditions, and we believe that we have the right people, the right knowledge and the right drug to make a difference in patients’ lives.

Our Mission
To create positive stories for patients, physicians and caregivers based on trust and integrity. To accomplish this, our employees work hard to turn everyday decisions into everyday triumphs that advance our technology and strengthen Paratek.

Our Vision
To be a leading independent biopharmaceutical company providing novel life-saving products for life-threatening diseases or other public health threats.

Section iconCompany Overview

Headquarters
75 Park Plaza, 4th Floor Boston, MA 02116, US
Phone number
Stock Symbol
PRTK
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1996
Employees
201-500

Section iconFunding & Financials

  • $250M$500M

    Paratek Pharmaceuticals's revenue is estimated to be in the range of $250M$500M

Section iconFunding & Financials

  • $250M$500M

    Paratek Pharmaceuticals's revenue is estimated to be in the range of $250M$500M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.